Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2021 Financial Results
10 mai 2021 16h05 HE
|
Longboard Pharmaceuticals, Inc.
Commenced multiple ascending dose (MAD) portion of the Phase 1 study for LP352, a potential treatment for severe epileptic indications; topline results expected in the second half of 2021 ...
VERUS INTERNATIONAL REPORTS FISCAL Q1 2021 FINANCIAL RESULTS; REALIZES 73% IMPROVEMENT IN OPERATING COSTS
29 mars 2021 07h30 HE
|
Verus International, Inc.
Gaithersburg, MD, March 29, 2021 (GLOBE NEWSWIRE) -- Verus International, Inc. (“Verus” or the “Company”) (OTC Pink: VRUS) reported financial results for the fiscal 2021 first quarter ended January...